Lodin Marco, Ragni Alberto, Renzelli Valerio, Rossi Maura, Traverso Elena Silvia, Gallo Marco
General Surgery Unit, Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy.
Endocrinology and Metabolic Diseases Unit, Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy.
Endocr Metab Immune Disord Drug Targets. 2024 Oct 10. doi: 10.2174/0118715303337748240910093934.
The diagnostic workup of an adrenal mass should always rule out the possibility of an adrenal metastasis, especially in a patient followed-up for a known primitive cancer. Sometimes, however, the incidental finding of a bulky lesion in a cancer patient can lead to the unexpected diagnosis of metastasis from a second occult cancer. Here, we report the case of a voluminous, isolated left adrenal metastasis from unknown and persistently occult hepatocellular carcinoma (HCC), incidentally found during the follow-up for squamous carcinoma of the tongue.
A 72-year-old HBV/HCV-negative male patient with a history of alcohol abuse was referred to our hospital for gastric bleeding. Some weeks before, the patient was operated on for a locally advanced squamous cell carcinoma of the tongue, which required cervical lymph node neck dissection, temporary tracheostomy, jejunostomy, and plastic reconstruction. Subsequent diagnostic imaging revealed a left adrenal mass sized 9x15 cm with suspicious features. The hormonal workout was negative for pheochromocytoma and a hyperfunctioning adrenal lesion. The patient underwent laparotomic left adrenalectomy. The exploration of the liver was compatible with alcoholic cirrhosis and did not reveal any other palpable lesion. The adrenal mass histologically turned out to be a poorly differentiated G3 HCC. Subsequent radiological exams were unable to identify the primary liver lesion or any other neoplasms. Conversely, α-FP levels were initially high but reduced after treatment with sorafenib. After 2 years of follow-up, the patient is alive and well, albeit with evidence of locoregional inter-aortocaval lymphadenopathy. The primary HCC has never been identified, thus suggesting the hypothesis of a diffuse cirrhosis-like HCC.
The suspicion of an adrenal metastasis in a patient with primary cancer with a low potential for adrenal metastatic spreading must raise the diagnostic suspect for another synchronous occult cancer beyond that for primary adrenal cancer. HCC can rarely first manifest as a metastatic adrenal lesion.
肾上腺肿块的诊断检查应始终排除肾上腺转移的可能性,尤其是在对已知原发性癌症进行随访的患者中。然而,有时癌症患者偶然发现的巨大病变可能会导致意外诊断为来自另一种隐匿性癌症的转移。在此,我们报告一例因舌鳞状细胞癌随访期间偶然发现的、来自不明且持续隐匿的肝细胞癌(HCC)的巨大孤立性左肾上腺转移病例。
一名72岁、乙肝/丙肝阴性、有酗酒史的男性患者因胃出血被转诊至我院。几周前,该患者因局部晚期舌鳞状细胞癌接受手术,手术包括颈部淋巴结清扫、临时气管切开术、空肠造口术和整形重建。随后的诊断性影像学检查发现左肾上腺有一个大小为9×15 cm的肿块,具有可疑特征。激素检查排除了嗜铬细胞瘤和肾上腺功能亢进性病变。患者接受了剖腹左肾上腺切除术。肝脏探查结果符合酒精性肝硬化,未发现其他可触及的病变。肾上腺肿块组织学检查结果为低分化G3 HCC。随后的影像学检查未能发现原发性肝脏病变或任何其他肿瘤。相反,α-FP水平最初较高,但在接受索拉非尼治疗后降低。经过2年的随访,患者存活且状况良好,尽管存在局部区域主动脉腔静脉间淋巴结肿大。原发性HCC从未被发现,因此提示弥漫性肝硬化样HCC的假说。
对于原发性癌症患者,若肾上腺转移扩散可能性较低,但怀疑有肾上腺转移,必须提高对另一种同步隐匿性癌症的诊断怀疑,而不仅仅是原发性肾上腺癌。HCC很少首先表现为转移性肾上腺病变。